Compare FDC with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -2.21% of over the last 5 years
Falling Participation by Institutional Investors
Stock DNA
Pharmaceuticals & Biotechnology
INR 5,487 Cr (Small Cap)
18.00
37
1.49%
-0.20
11.98%
2.20
Total Returns (Price + Dividend) 
Latest dividend: 5 per share ex-dividend date: Feb-11-2026
Risk Adjusted Returns v/s 
Returns Beta
News

FDC Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges
FDC Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from fair to attractive territory. Despite recent share price pressures and a downgraded overall mojo grade, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value in a challenging market environment.
Read full news article
FDC Ltd is Rated Sell by MarketsMOJO
FDC Ltd is rated Sell by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 October 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
FDC Ltd is Rated Sell by MarketsMOJO
FDC Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article Announcements 
Shareholder Meeting / Postal Ballot-Scrutinizers Report
28-Sep-2026 | Source : BSEDisclosure of Voting results of the 86th Annual general Meeting held on 24th September 2026 along with the Scrutinizers Report.
Closure of Trading Window
25-Sep-2026 | Source : BSETrading window of the Company shall remain closed for all the Designated Persons and their relatives with effect from 1st October 2026 till 48 hours after the declaration of Unaudited Financial results of the Company for the quarter and half year ending on 30th September 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
24-Sep-2026 | Source : BSEProceedings of the 86th Annual General Meeting held on Thursday 24th September 2026.
Corporate Actions 
No Upcoming Board Meetings
FDC Ltd has declared 500% dividend, ex-date: 11 Feb 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 5 Schemes (6.25%)
Held by 74 FIIs (1.4%)
Nomita R Chandavarkar (22.67%)
Icici Prudential Smallcap Fund (2.8%)
17.64%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 14.18% vs 25.84% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 28.13% vs 265.37% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -2.66% vs 12.65% in Sep 2024
Growth in half year ended Sep 2025 is -21.65% vs 6.33% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -1.86% vs 9.14% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -21.96% vs -11.90% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 2.98% vs 8.50% in Mar 2025
YoY Growth in year ended Mar 2026 is 5.48% vs -12.59% in Mar 2025






